Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Preferred Shares (2020 - 2023)

Ovid Therapeutics' Preferred Shares history spans 4 years, with the latest figure at $1.0 for Q3 2023.

  • For Q3 2023, Preferred Shares changed 0.0% year-over-year to $1.0; the TTM value through Sep 2023 reached $1.0, changed 0.0%, while the annual FY2022 figure was $1.0, 0.0% changed from the prior year.
  • Preferred Shares reached $1.0 in Q3 2023 per OVID's latest filing, roughly flat from $1.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $8.0 in Q1 2020 to a low of $1.0 in Q1 2021.
  • Average Preferred Shares over 4 years is $2.27, with a median of $1.0 recorded in 2021.
  • Peak YoY movement for Preferred Shares: plummeted 87.5% in 2021, then changed 0.0% in 2022.
  • A 4-year view of Preferred Shares shows it stood at $3.0 in 2020, then crashed by 66.67% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
  • Per Business Quant, the three most recent readings for OVID's Preferred Shares are $1.0 (Q3 2023), $1.0 (Q2 2023), and $1.0 (Q1 2023).